Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Google backs Indian mobile online doctor community

Curofy wins support from the firm's Launchpad Accelerator programme

Digital pharma CurofyA new online mobile network for doctors is among the startups to receive the backing of Google's Launchpad Accelerator programme.

Curofy claims to be India's largest online community of verified doctors, with over 190,000 members from more than 600 cities.

Its flagship app, which is available for both Apple and Android devices, allows them to discuss medical cases and provides access to medical news and jobs. 

Curofy's co-founder Pawan Gupta told BWDisrupt: "Google Accelerator provides a great opportunity for Indian startups to be mentored in best product and engineering practices followed in Silicon Valley. The learning and exposure from the accelerator will prepare Curofy's product for its growth beyond India".

As it does so one of its competitors will likely be MedShr, which was launched last year by a UK doctor as a similarly mobile-first social work.

Curofy, which is based near New Delhi in Gurgaon, joins the third wave of startups in the Google's Launchpad programme, among them a word game app and one for CRM.

The companies are now inline for six months mentorship and a share of $50,000 in equity-free funding.

20th December 2016

From: Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
claire@dovetailstrategies.com

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...
white house
Eliminating pharmaceutical rebates, is this déjà vu?
By Andrew Parece and Matthew Majewski...
Patients are ready to embrace decentralised clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...

Infographics